BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu Y, Zhang Y, Qin X, Geng H, Zuo D, Zhao Q. PI3K/AKT/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma. Pharmacol Res 2020;160:105195. [PMID: 32916254 DOI: 10.1016/j.phrs.2020.105195] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou X, Li TM, Luo JZ, Lan CL, Wei ZL, Fu TH, Liao XW, Zhu GZ, Ye XP, Peng T. CYP2C8 Suppress Proliferation, Migration, Invasion and Sorafenib Resistance of Hepatocellular Carcinoma via PI3K/Akt/p27kip1 Axis. J Hepatocell Carcinoma 2021;8:1323-38. [PMID: 34765572 DOI: 10.2147/JHC.S335425] [Reference Citation Analysis]
2 Du P, Luo K, Li G, Zhu J, Xiao Q, Li Y, Zhang X. PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis. Int J Med Sci 2021;18:3588-98. [PMID: 34522186 DOI: 10.7150/ijms.62467] [Reference Citation Analysis]
3 Yang L, Zou T, Chen Y, Zhao Y, Wu X, Li M, Du F, Chen Y, Xiao Z, Shen J. Hepatitis B virus X protein mediated epigenetic alterations in the pathogenesis of hepatocellular carcinoma. Hepatol Int 2022. [PMID: 35648301 DOI: 10.1007/s12072-022-10351-6] [Reference Citation Analysis]
4 Li L, Chen T, Wang J, Li M, Li Q, Wang F. Identification of an Autophagy-Related Signature Based on Whole Bone Marrow Sequencing for the Prognosis and Immune Microenvironment Characterization of Multiple Myeloma. Journal of Immunology Research 2022;2022:1-14. [DOI: 10.1155/2022/3922739] [Reference Citation Analysis]
5 Guo M, Li N, Zheng J, Wang W, Wu Y, Han X, Guo J, Chen W, Bai Z, Bai W, Wu J. Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway. Can J Gastroenterol Hepatol 2021;2021:5596712. [PMID: 34123955 DOI: 10.1155/2021/5596712] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Chen Y, Gong S, Liu Y, Cao X, Zhao M, Xiao J, Feng C. Geraniin inhibits cell growth and promoted autophagy-mediated cell death in the nasopharyngeal cancer C666-1 cells. Saudi J Biol Sci 2022;29:168-74. [PMID: 35002405 DOI: 10.1016/j.sjbs.2021.08.076] [Reference Citation Analysis]
7 Zhou W, Gao Y, Tong Y, Wu Q, Zhou Y, Li Y. Anlotinib enhances the antitumor activity of radiofrequency ablation on lung squamous cell carcinoma. Pharmacol Res 2021;164:105392. [PMID: 33348023 DOI: 10.1016/j.phrs.2020.105392] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
8 Wang M, Xu T, Feng W, Liu J, Wang Z. Advances in Understanding the LncRNA-Mediated Regulation of the Hippo Pathway in Cancer. Onco Targets Ther 2021;14:2397-415. [PMID: 33854336 DOI: 10.2147/OTT.S283157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Shu G, Su H, Wang Z, Lai S, Wang Y, Liu X, Dai L, Bi Y, Chen W, Huang W, Zhou Z, He S, Dai H, Tang B. LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3. J Exp Clin Cancer Res 2021;40:45. [PMID: 33499874 DOI: 10.1186/s13046-021-01854-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Chen Y, Pan B, Qiu J, Chen Z, Wang X, Tang N. Increased effects of 2,5-dimethylcelecoxib on sensitivity of hepatocellular carcinoma cells to sorafenib via CYP3A5 expression and activation of AMPK. Toxicol In Vitro 2021;76:105226. [PMID: 34293431 DOI: 10.1016/j.tiv.2021.105226] [Reference Citation Analysis]
11 Xu F, Hua Q, Zhang A, Di Z, Wang Y, Zhao L, Yang H, Liu J, Huang G. LncRNA AC020978 facilitates non-small cell lung cancer progression by interacting with malate dehydrogenase 2 and activating the AKT pathway. Cancer Sci 2021;112:4501-14. [PMID: 34424600 DOI: 10.1111/cas.15116] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Song X, Guo Y, Song P, Duan D, Guo W. Non-coding RNAs in Regulating Tumor Angiogenesis. Front Cell Dev Biol 2021;9:751578. [PMID: 34616746 DOI: 10.3389/fcell.2021.751578] [Reference Citation Analysis]
13 Mu Y, Ren XH, Han D, Guan YY, Liu PL, Cheng SX, Liu H. Codelivery of HBx-siRNA and Plasmid Encoding IL-12 for Inhibition of Hepatitis B Virus and Reactivation of Antiviral Immunity. Pharmaceutics 2022;14:1439. [PMID: 35890334 DOI: 10.3390/pharmaceutics14071439] [Reference Citation Analysis]
14 Najafi S, Khatami SH, Khorsand M, Jamali Z, Shabaninejad Z, Moazamfard M, Majidpoor J, Aghaei Zarch SM, Movahedpour A. Long non-coding RNAs (lncRNAs); roles in tumorigenesis and potentials as biomarkers in cancer diagnosis. Exp Cell Res 2022;:113294. [PMID: 35870535 DOI: 10.1016/j.yexcr.2022.113294] [Reference Citation Analysis]
15 Teng YJ, Deng Z, Ouyang ZG, Zhou Q, Mei S, Fan XX, Wu YR, Long HP, Fang LY, Yin DL, Zhang BY, Guo YM, Zhu WH, Huang Z, Zheng P, Ning DM, Tian XF. Xihuang pills induce apoptosis in hepatocellular carcinoma by suppressing phosphoinositide 3-kinase/protein kinase-B/mechanistic target of rapamycin pathway. World J Gastrointest Oncol 2022; 14(4): 872-886 [DOI: 10.4251/wjgo.v14.i4.872] [Reference Citation Analysis]
16 Zhu XL, Li Q, Shen J, Shan L, Zuo ED, Cheng X. Use of 6 m6A-relevant lncRNA genes as prognostic markers of primary liver hepatocellular carcinoma based on TCGA database. Transl Cancer Res 2021;10:5337-51. [PMID: 35116381 DOI: 10.21037/tcr-21-2440] [Reference Citation Analysis]
17 Liu J, Yang C, Huang XM, Lv PP, Yang YK, Zhao JN, Zhao SY, Sun WJ. Knockdown of FBI-1 Inhibits the Warburg Effect and Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular Targeted Agents via miR-3692/HIF-1α. Front Oncol 2021;11:796839. [PMID: 34869045 DOI: 10.3389/fonc.2021.796839] [Reference Citation Analysis]
18 Zhang S, Lu Y, Jiang HY, Cheng ZM, Wei ZJ, Wei YH, Liu T, Xia BJ, Zhao XY, Huang Y, Zou X, Liu R, Zhou S. CircC16orf62 promotes hepatocellular carcinoma progression through the miR-138-5p/PTK2/AKT axis. Cell Death Dis 2021;12:597. [PMID: 34108451 DOI: 10.1038/s41419-021-03866-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Han X, Zhang S. Role of Long Non-Coding RNA LINC00641 in Cancer. Front Oncol 2021;11:829137. [PMID: 35155216 DOI: 10.3389/fonc.2021.829137] [Reference Citation Analysis]
20 Liu H, Zhao L, Wang M, Yang K, Jin Z, Zhao C, Shi G. FNDC5 Causes Resistance to Sorafenib by Activating the PI3K/Akt/Nrf2 Pathway in Hepatocellular Carcinoma Cells. Front Oncol 2022;12:852095. [PMID: 35392237 DOI: 10.3389/fonc.2022.852095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Chen J, Wen B, Wang Y, Wu S, Zhang X, Gu Y, Wang Z, Wang J, Zhang W, Yong J. Jervine exhibits anticancer effects on nasopharyngeal carcinoma through promoting autophagic apoptosis via the blockage of Hedgehog signaling. Biomed Pharmacother 2020;132:110898. [PMID: 33113432 DOI: 10.1016/j.biopha.2020.110898] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Wang JH, Zeng Z, Sun J, Chen Y, Gao X. A novel small-molecule antagonist enhances the sensitivity of osteosarcoma to cabozantinib in vitro and in vivo by targeting DNMT-1 correlated with disease severity in human patients. Pharmacol Res 2021;173:105869. [PMID: 34481973 DOI: 10.1016/j.phrs.2021.105869] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Liao H, Jiang H, Chen Y, Duan T, Yang T, Han M, Xue Z, Shi F, Yuan K, Bashir MR, Shen D, Song B, Zeng Y. Predicting Genomic Alterations of Phosphatidylinositol-3 Kinase Signaling in Hepatocellular Carcinoma: A Radiogenomics Study Based on Next-Generation Sequencing and Contrast-Enhanced CT. Ann Surg Oncol 2022. [PMID: 35286532 DOI: 10.1245/s10434-022-11505-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Xu L, Yang C, Wang J, Li Z, Huang R, Ma H, Ma J, Wang Q, Xiong X. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice. Biochem Biophys Res Commun 2021;578:142-9. [PMID: 34562654 DOI: 10.1016/j.bbrc.2021.09.036] [Reference Citation Analysis]